Which of the following statements is WRONG about amiodarone?
**Core Concept**
Amiodarone is a class III antiarrhythmic medication used to treat various types of cardiac arrhythmias. It works by blocking potassium channels, which prolongs the action potential duration and refractory period in the heart.
**Why the Correct Answer is Right**
The correct statement about amiodarone is that it is primarily metabolized in the liver and its active metabolite, desethylamiodarone, contributes to its therapeutic and toxic effects. Amiodarone's complex pharmacokinetic profile involves both hepatic metabolism and biliary excretion, with a large volume of distribution due to its lipophilic nature.
**Why Each Wrong Option is Incorrect**
**Option A:** Amiodarone is known for its iodine content, which can lead to thyroid dysfunction, but the statement is incomplete as it does not specify the type of thyroid dysfunction. Furthermore, amiodarone can cause both hypothyroidism and hyperthyroidism.
**Option B:** Amiodarone does have a narrow therapeutic index, but this is more relevant to its cardiotoxic effects rather than its pharmacokinetics.
**Option C:** Amiodarone is indeed a long-acting antiarrhythmic medication, but this statement is too vague and does not address the specific pharmacokinetic or pharmacodynamic properties of amiodarone.
**Clinical Pearl / High-Yield Fact**
Amiodarone's lipophilic nature and complex pharmacokinetic profile contribute to its potential for causing pulmonary toxicity, liver injury, and thyroid dysfunction, making it essential to monitor patients closely for these side effects.
**Correct Answer:** None of the above statements are specifically wrong about amiodarone, as the options provided do not accurately capture the medication's pharmacokinetic profile or potential side effects.